# Sware

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sware

- Industry: Software
- Headquarters: Chelsea, US
- Website: www.sware.com
- Total disclosed funding: $22M
- Latest round: Series B (Apr 17, 2024)
- Investors on record: 6

## About

Based in Massachusetts, US, and founded in 2015, Sware, Inc., formerly known as Boston Technology Research Corp., operates as a software technology company. The company was founded by its president, Bryan Ennis. In April 2024, Sware, Inc. raised USD 6.02 million in Series B funding led by First Analysis, Insight Partners, New Stack Ventures, and LRVHealth. The series A funding values Sware, Inc. at USD 15.13 million post-money. As of 2024, the company is led by its CEO, Ellen Reilly.

The company’s product line includes Res_Q, which is a validation platform designed to automate and manage compliance tasks; and GxPNext, which is a software development lifecycle (SDLC) solution designed specifically for companies operating in GxP-regulated industries.

The company plans to use the funds raised in April 2024 to accelerate the research and development of its Res_Q computer systems validation (CSV) platform and to expand its sales team.

## Funding rounds

- Series B, Apr 17, 2024, $6M — First Analysis, Insight Partners, LRVHealth, New Stack Ventures
- Series A, Jan 26, 2022, $13M — Insight Partners, LRVHealth, Global Venture Capital, New Stack Ventures
- Seed, May 11, 2021, $3.2M — Jumpstart Health Investors

## Investors

- Jumpstart Health Investors (https://capitalatlas.ai/funds/jumpstart-health-investors) — Seed
- Insight Partners (https://capitalatlas.ai/funds/insight-partners) — Series A, Series B
- LRVHealth (https://capitalatlas.ai/funds/lrvhealth) — Series A, Series B
- Global Venture Capital (https://capitalatlas.ai/funds/global-venture-capital) — Series A
- New Stack Ventures (https://capitalatlas.ai/funds/new-stack-ventures) — Series A, Series B
- First Analysis (https://capitalatlas.ai/funds/first-analysis) — Series B